Table 3.

Risk of primary and secondary outcomes in anatomic subgroups

Variables	No. of Patients	No. of Events	Event Rate (%) (KM Estimate)	Hazard Ratio (95% CI)	P-value	P-value for interaction
Outcome: Death
3 Diseased Vessels						0.23
EES	541	95	24.7	1.15[0.81,1.61]	0.44
CABG	541	93	24.0	Reference
2 Diseased Vessels
EES	779	88	17.7	0.86[0.61,1.19]	0.35
CABG	779	108	18.1	Reference
Outcome: Myocardial Infarction
3 Diseased Vessels						0.04
EES	541	51	13.8	2.75[1.55,4.87]	0.0005
CABG	541	24	6.1	Reference
2 Diseased Vessels
EES	779	45	8.0	1.26[0.76,2.09]	0.37
CABG	779	36	6.3	Reference
Outcome: Repeat Revascularization
3 Diseased Vessels						0.05
EES	541	125	32.0	3.75[2.47,5.69]	<0.0001
CABG	541	44	10.4	Reference
2 Diseased Vessels
EES	779	134	22.2	2.18[1.56,3.03]	<0.0001
CABG	779	68	12.5	Reference
Outcome: Death
Complete Revascularization						0.89
EES	541	72	16.9	1.09[0.76,1.58]	0.64
CABG	541	74	18.4	Reference
Incomplete revascularization*
EES	2419	386	23.9	1.06[0.90,1.25]	0.48
CABG	2419	395	21,0	Reference
Outcome: Myocardial Infarction
Complete Revascularization						0.13
EES	541	33	8.3	1.18[0.67,2.09]	0.56
CABG	541	33	8.56	Reference
Incomplete Revascularization*
EES	2419	200	11.2	1.91[1.48,2.47]	<0.0001
CABG	2419	120	6.5	Reference
Outcome: Repeat Revascularization
Complete Revascularization						0.05
EES	541	79	19.8	1.68[1.13,2.48]	0.01
CABG	541	61	15.9	Reference
Incomplete Revascularization*
EES	2419	503	27.5	2.60[2.17,3.13]	<0.0001
CABG	2419	223	12.4	Reference

^*Based on incomplete revascularization in the PCI group.

CABG = coronary artery bypass graft surgery; EES = everolimus eluting stent.